The University of Chicago Header Logo

Connection

Gini Fleming to Pyrimidinones

Back to Details
This is a "connection" page, showing publications Gini Fleming has written about Pyrimidinones.
Gini Fleming
Connection Strength
0.193
Pyrimidinones
  1. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021 01 23; 397(10271):281-292.
    View in: PubMed
    Score: 0.193
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.